Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap

le Locke, Frederick L., Anasetti, Claudio
Foilsithe in J Immunother Cancer (2017)

Off-the-shelf TCR for graft-versus-leukemia without GVHD

le Locke, Frederick L., Anasetti, Claudio
Foilsithe in Blood (2018)

Beat pediatric ALL MRD: CD28 CAR T and transplant

le Ruella, Marco, Locke, Frederick L.
Foilsithe in Blood (2019)

A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction

le Chavez, Julio C., Locke, Frederick L.
Foilsithe in Mol Ther (2017)

CAR T cell therapy for B-cell lymphomas

le Chavez, Julio C., Locke, Frederick L.
Foilsithe in Best Pract Res Clin Haematol (2018)

Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma: A Review

le Locke, Frederick L., Go, William Y., Neelapu, Sattva S.
Foilsithe in JAMA Oncol (2020)

The roles of T cell competition and stochastic extinction events in chimeric antigen receptor T cell therapy

le Kimmel, Gregory J., Locke, Frederick L., Altrock, Philipp M.
Foilsithe in Proc Biol Sci (2021)

Immunotherapy strategies for multiple myeloma: the present and the future

le Locke, Frederick L, Nishihori, Taiga, Alsina, Melissa, Kharfan-Dabaja, Mohamed A
Foilsithe in Immunotherapy (2013)

Conditional deletion of PTEN in peripheral T cells augments TCR-mediated activation but does not abrogate CD28 dependency or prevent anergy induction

le Locke, Frederick L., Zha, Yuan-yuan, Zheng, Yan, Driessens, Gregory, Gajewski, Thomas F.
Foilsithe 2013

Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma

le Locke, Frederick L, Menges, Meghan, Veerapathran, Anandharaman, Coppola, Domenico, Gabrilovich, Dmitry, Anasetti, Claudio
Foilsithe in J Immunother Cancer (2015)

Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chro...

le Chavez, Julio C., Kharfan-Dabaja, Mohamed A., Kim, Jongphil, Yue, Binglin, Dalia, Samir, Pinilla-Ibarz, Javier, Anasetti, Claudio, Locke, Frederick L.
Foilsithe in Leuk Res (2014)

Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

le Maziarz, Richard T., Schuster, Stephen J., Romanov, Vadim V., Rusch, Elisha S., Li, Junlong, Signorovitch, James E., Maloney, David G., Locke, Frederick L.
Foilsithe in Blood Adv (2020)

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

le Schuster, Stephen J., Maziarz, Richard T., Rusch, Elisha S., Li, Junlong, Signorovitch, James E., Romanov, Vadim V., Locke, Frederick L., Maloney, David G.
Foilsithe in Blood Adv (2020)

Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients

le Hampras, Shalaka S., Locke, Frederick L., Chavez, Julio C., Patel, Nishit S., Giuliano, Anna R., Miller, Kyle, Gheit, Tarik, Tommasino, Massimo, Rollison, Dana E.
Foilsithe in Leuk Lymphoma (2017)

Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

le Kharfan-Dabaja, Mohamed A., Jain, Michael D., Aulakh, Sonikpreet, Ayala, Ernesto, Zubair, Abba C., Tun, Han W., Liu, Hien D., Locke, Frederick L., Chavez, Julio C.
Foilsithe in Am J Hematol (2019)

Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center Experience

le Kharfan-Dabaja, Mohamed A., Kumar, Ambuj, Stingo, Facundo E., Khimani, Farhad, Hussaini, Mohammad, Ayala, Ernesto, Nishihori, Taiga, Shah, Bijal, Locke, Frederick L., Pinilla-Ibarz, Javier, Chavez, Julio C.
Foilsithe in Clin Lymphoma Myeloma Leuk (2017)

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit ‘ALL’

le Neelapu, Sattva S., Tummala, Sudhakar, Kebriaei, Partow, Wierda, William, Locke, Frederick L., Lin, Yi, Jain, Nitin, Daver, Naval, Gulbis, Alison M., Adkins, Sherry, Rezvani, Katayoun, Hwu, Patrick, Shpall, Elizabeth J.
Foilsithe in Nat Rev Clin Oncol (2018)

Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease

le Frairia, Chiara, Nicolosi, Maura, Shapiro, Jamie, Kim, Jongphil, Betts, Brian C., Fernandez, Hugo F., Locke, Frederick L., Mishra, Asmita, Nishihori, Taiga, Ochoa-Bayona, Jose Leonel, Perez, Lia, Pidala, Joseph, Anasetti, Claudio
Foilsithe in Biol Blood Marrow Transplant (2020)

Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma

le Neelapu, Sattva S., Jacobson, Caron A., Oluwole, Olalekan O., Munoz, Javier, Deol, Abhinav, Miklos, David B., Bartlett, Nancy L., Braunschweig, Ira, Jiang, Yizhou, Kim, Jenny J., Zheng, Lianqing, Rossi, John M., Locke, Frederick L.
Foilsithe in Blood (2020)

Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft-versus-Host Disease: Phase I Trial Results

le Pidala, Joseph, Kim, Jongphil, Betts, Brian C., Alsina, Melissa, Ayala, Ernesto, Fernandez, Hugo F., Field, Teresa, Kharfan-Dabaja, Mohamed A., Locke, Frederick L., Mishra, Asmita, Nishihori, Taiga, Ochoa-Bayona, Leonel, Perez, Lia, Riches, Marcie, Anasetti, Claudio
Foilsithe in Biol Blood Marrow Transplant (2015)